GGrantIndex
Sort

141,003 grants matching cytokine

DARC, Inflammaging and Alzheimer's Disease

$757,132
Xin-Yun Lu · Augusta University · R01 · FY2024 · AG

Contribution of novel lysoplasmalogenases enzymes in regulating macrophage immunometabolic responses in cardiovascular disease

$757,122
Carlos Fernandez Hernando · Yale University · R01 · FY2025 · HL

Role of TIM-3 in Regulating CNS Autoimmune Responses

$757,115
David A. Hafler · Brigham And Women'S Hospital · P01 · FY2009 · AI

Immunological characterization of rationally-designed vaccines against plague in mice and non-human primate models

$757,093
Ashok K Chopra · University Of Texas Med Br Galveston · R01 · FY2024 · AI

Multiscale Analysis of Trauma

$757,074
Scott L Diamond · University Of Pennsylvania · U01 · FY2017 · HL

Ubiquitin pathway inhibitors for treatment of asthma

$757,044
Kumar Suresh · Progenra, Inc. · R44 · FY2017 · AI

HIV Infection, Cocaine Use and Coronary Artery Disease in HIV+ African Americans

$757,014
Shenghan Lai · Johns Hopkins University · R01 · FY2009 · DA

Dopaminergic and Neuroplastic Influences on Longitudinal Change in Cognitive and Brain Aging

$756,994
Kristen M. Kennedy · University Of Texas Dallas · R01 · FY2024 · AG

Perturbing the HIV Reservoir with Immune Stimulation

$756,978
David Mitchell Smith · University Of California, San Diego · R01 · FY2020 · AI

Nonlipogenic ABCA1 inducers for ADRD

$756,926
Gregory R J Thatcher · University Of Arizona · U01 · FY2022 · AG

Animal Model for SIV Infection Control

$756,918
Cristian Apetrei · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · RR

CLINICAL/EXPERIMENTAL RADIATION RESEARCH

$756,911
University Of Rochester · P01 · FY2001 · CA

Developing a Multi-epitope Pan-Coronavirus Vaccine

$756,900
Lbachir Benmohamed · University Of California-Irvine · R01 · FY2022 · AI

The NET Impact on Lung Epithelia in Cystic Fibrosis and Mucoobstruction

$756,875
Kristin Mara Hudock · University Of Cincinnati · R01 · FY2025 · HL

Saracatinib and 1400W Counteract Nerve Agents-Induced Long-Term Neurotoxicity

$756,847
Thimmasettappa Thippeswamy · Iowa State University · U01 · FY2024 · NS

Investigating the role of the microbiome and inflammation in acute and chronic pain in patients with sickle cell disease

$756,772
Amanda M Brandow · Medical College Of Wisconsin · R01 · FY2019 · HL

Impact of illicit drugs, HIV, and ART on neuroinflammation and BBB disruption

$756,652
Joan Weinberger Berman · Albert Einstein College Of Medicine · R01 · FY2019 · DA

Immunologic Basis for Broad Protection against Enteric Fever Salmonella

$756,625
Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2014 · AI

Development of a hamster model for hepatitis B virus infection

$756,589
Zhongde Wang · Utah State University · R01 · FY2024 · AI

CD4 Redirected Chimeric Antigen Receptor T Cell Therapy for CD4 Positive T Cell Neoplasms

$756,574
Huda Salman · Indiana University Indianapolis · R01 · FY2025 · FD

Project 1: Microbiology of ME/CFS

$756,543
W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2021 · AI

New Paradigms in Gene Regulation During Influenza Virus Infections

$756,534
Curt M Horvath · Northwestern University · U01 · FY2009 · AI

The impact of illness and medical treatments on the alloantibody response to platelet transfusion

$756,531
Rachael Peretz Jackman · Vitalant · R01 · FY2019 · HL

New approach for immune modulation against T1D

$756,491
Weston Daniel · Evoq Therapeutics, Inc. · R44 · FY2024 · DK

Elucidating Genetic Determinants of Resistance to Lassa Hemorrhagic Fever

$756,479
Pardis Christine Sabeti · Broad Institute, Inc. · R01 · FY2017 · AI